New anticancer treatment

10 currently open clinical trials

Combined therapy for mantle cell lymphoma
SAKK 36/13
Radio-chemotherapy improvement for locally advanced rectal cancer
SAKK 41/16
Dosage of a new targeted drug for the treatment of lung cancer
SAKK 19/16
A phase I trial with TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors
SAKK 65/16
Stimulating the immune system to fight against squamous cell carcinoma
SAKK 11/16
NAPAGE: Nab-paclitaxel and gemcitabine for advanced soft tissue sarcomas
SAKK 57/16
Determination of the maximum tolerated dose of a new Microtubule Targeting Agent on adult patients with a recurrent solid tumor
SAKK 67/15
A phase I trial of LY3200882 in patients with solid tumors (oral TGFβ inhibitor)
SAKK 68/17
Trial with the ATR Inhibitor BAY-1895344 in Patients with advanced solid Tumors and Lymphomas (first use in humans)
SAKK 69/17
Combination therapy with copanlisib and venetoclax in B-cell non-Hodgkin’s lymphoma
SAKK 66/18
All cancer types